Cancer

Explore the complexities of Cancer research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against cancer with flcube.com.

AstraZeneca's Imfinzi Combo Cuts Death Risk 42% in Phase III VOLGA Trial – Landmark Perioperative Win in Muscle-Invasive Bladder Cancer
CompanyDrug

AstraZeneca’s Imfinzi Combo Cuts Death Risk 42% in Phase III VOLGA Trial – Landmark Perioperative Win in Muscle-Invasive Bladder Cancer

AstraZeneca plc (NYSE: AZN) presented high-level results from a prespecified interim analysis of the Phase III VOLGA clinical trial at the 2026 European Society for Medical Oncology (ESMO) Congress, showing…

InnoCare Pharma Q3 Revenue Surges 150.6% as Orelabrutinib Expansion Drives Turnaround to Profitability

InnoCare Pharma Q3 Revenue Surges 150.6% as Orelabrutinib Expansion Drives Turnaround to Profitability

Novartis Raises Full-Year Core Profit Guidance as Q3 Sales Grow 4% – Kisqali Surges 37% to Lead Priority Brands

Novartis Raises Full-Year Core Profit Guidance as Q3 Sales Grow 4% – Kisqali Surges 37% to Lead Priority Brands

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Shanghai Henlius Biotech Earns GMP Certification for Prolia/Xgeva Biosimilar HLX14 and Perjeta Biosimilar HLX11
CompanyDrug

Shanghai Henlius Biotech Earns GMP Certification for Prolia/Xgeva Biosimilar HLX14 and Perjeta Biosimilar HLX11

Dizal’s Sunvozertinib Receives FDA Accelerated Approval for EGFR Exon20ins NSCLC
CompanyDrug

Dizal’s Sunvozertinib Receives FDA Accelerated Approval for EGFR Exon20ins NSCLC

Sichuan Biokin's Iza-bren Meets Primary Endpoint in Phase III NPC Trial
CompanyDrug

Sichuan Biokin’s Iza-bren Meets Primary Endpoint in Phase III NPC Trial

Genrix Bio Receives NMPA Clearance for GR1803 in Relapsed/Refractory Multiple Myeloma
CompanyDrug

Genrix Bio Receives NMPA Clearance for GR1803 in Relapsed/Refractory Multiple Myeloma

Simcere Pharma's Suvemcitug Approved by China's NMPA for Platinum-Resistant Ovarian Cancer
CompanyDrug

Simcere Pharma’s Suvemcitug Approved by China’s NMPA for Platinum-Resistant Ovarian Cancer

AbbVie's Venclexta Approved by China's NMPA for CLL/SLL Patients with 17p Deletion
CompanyDrug

AbbVie’s Venclexta Approved by China’s NMPA for CLL/SLL Patients with 17p Deletion

InnoCare Pharma Receives NMPA Clinical Approval for Innovative ADC B7-H3
CompanyDrug

InnoCare Pharma Receives NMPA Clinical Approval for Innovative ADC B7-H3

Anhui Anke Biotechnology Receives NMPA Clearance for AK2024 in HER2 Positive Solid Tumors
CompanyDrug

Anhui Anke Biotechnology Receives NMPA Clearance for AK2024 in HER2 Positive Solid Tumors

Show More